Reuters logo
BRIEF-Repros names Larry Dillaha M.D. its permanent president and CEO
April 10, 2017 / 1:35 PM / 7 months ago

BRIEF-Repros names Larry Dillaha M.D. its permanent president and CEO

April 10 (Reuters) - Repros Therapeutics Inc -

* Repros names Larry Dillaha, M.D., its permanent president and ceo

* Dillaha has also been named to board, filling an existing vacancy

* Dillaha was previously chief executive officer of Cavtherx, an inception stage biotechnology company

* Dillaha has been serving as president, chief executive officer on an interim basis since February 1, 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below